Universe Pharmaceuticals INC now has a reported 18.3% ownership position held by Origin Force Intelligence Limited, equal to 916,759 Class A ordinary shares. The position matters to investors because the reporting persons said the securities were not acquired or held to change or influence control of Universe Pharmaceuticals.
Key Highlights
- Origin Force Intelligence Limited reported 18.3% ownership of Universe Pharmaceuticals.
- The reported position consists of 916,759 Class A ordinary shares.
- The Schedule 13G identifies the ownership as passive under Rule 13d-1(c).
The ownership position is described as passive under Rule 13d-1(c), with the securities not acquired or held to change or influence control of Universe Pharmaceuticals (NASDAQ: UPC).
The documents list Universe Pharmaceuticals INC (NASDAQ: UPC) as a Cayman Islands exempted company with an address in Ji'an, Jiangxi, China.
Passive Status Limits Stated Control Purpose
The reporting persons certified that the securities were not acquired or held for the purpose of changing or influencing Universe Pharmaceuticals’ control. They also said the position was not held in connection with a transaction having that purpose, other than activities solely connected with a nomination under the cited rule.
FAQs
Q: What percentage of Universe Pharmaceuticals does Origin Force Intelligence own?
A: Origin Force Intelligence Limited reported ownership of 916,759 Class A ordinary shares, equal to 18.30% of the class. The percentage uses 5,008,313 shares outstanding as of July 27, 2026.
Q: Is the Universe Pharmaceuticals stake intended to change control?
A: The reporting persons classified the ownership as passive. They certified that the securities were not acquired or held to change or influence Universe Pharmaceuticals’ control.
Q: Who is identified as controlling Origin Force Intelligence Limited?
A: Piao Ye is identified as the individual who wholly owns and controls Origin Force Intelligence Limited. The filing also lists Piao Ye as the company’s director.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.